Beyond Innovations For Life
Our Scientific Advisory Board, including Dr. Napoleon Ferrara who developed Avastin, plays an important role in directing our R&D activities by providing insight and guidance to the discovery of novel therapeutic candidates.
Scientific Advisory Board
Napoleone Ferrera
Moores Cancer Center at UC San Diego
Senior Deputy Director for Basic Science
Distinguished Professor of Pathology at UCSD School of Medicine
Distinguished Adjunct Professor of Ophthalmology and Pharmacology at UCSD
Inventor of Avastin® and Lucentis®
Pioneer of the Angiogenesis Therapy in Oncology and Ophthalmology
David Cheresh
Moores Cancer Center at UC San Diego
Distinguished Professor and Vice Chair of Research at Pathology Dept.
Director for Translational Research at UCSD Moores Cancer Ctr.
Inventor of Unituxin® and Vitaxin®
Quan Dong Nguyen
Stanford Byers Eye Institute
Professor, Ophthalmology, Pediatrics, Stanford University School of Medicine
McGaw Endowed Chair/Professor, Ophthalmology, University of Nebraska Medical Center Stanley M. Truhlsen Eye Institute
Associate Professor, Johns Hopkins University Wilmer Eye Institute
MD, Medicine, University of Pennsylvania
MSc, Molecular Biophysics and Biochemistry, Yale University
Led clinical trials evaluating Eylea® for neovascular AMD and Lucentis® for DME, which served as the foundation for subsequent trials and FDA approval of anti-VEGF therapy
Soo-Hyeon Lee
Korea University Medical Center
Professor, Division of Hemato-oncology, Korea Univ. College of Medicine
Country Medical Director at Celgene
Korea Oncology Medical Lead at Pfizer
Consultant
Do-hyun Nam
Samsung Medical Center
PharmAbcine Inc, Co-founder
Chairman, Samsung Medical Center,’s Institute for Refractory Cancer Research
Professor, Department of Neurology, Sungkyunkwan School of Medicine
Head, Cancer Stem Cell Research Center, Samsung Medical Center
QA Clinic Ctr. at Samsung Medical Center
MD/Ph.D, School of Medicine, Seoul National University
Robert S. Kerbel
University of Toronto
Canada Research Chair (1 Tier) in Tumor Biology, Angiogenesis and Antiangiogenic Therapy
Professor, Medical Biophysics, University of Toronto
Senior Scientist, Sunnybrook Health Sciences Center
Director, Cancer Research Labs, Queen’s University
Post-Doc, Chester Beatty Research Institute
PhD, Microbiology and Immunology, Queen's University
BA, Life Sciences, University of Toronto
2F, Research Building 2, 70,
Yuseong-daero 1689 beon-gil,
Yuseong-gu, Daejeon, 34047, Republic of Korea
HQ +82-42-863-2017
R&D Center +82-42-861-2017
Investor Relations +70-4294-6097
FAX +82-42-863-2080
COPYRIGHT BY PharmAbcine Inc.
ALL RIGHTS RESERVE